Gentel Biosciences, Inc. – Trademark Portfolio
Entity Type: 03
Gentel Biosciences, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 6 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SILVERQUANT. The owner is based in Madison, WI.
5500 Nobel Drive, Suite 230
Madison, WI 53711
Showing of trademarks Trademarks
Trademark Classifications
Gentel Biosciences, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Gentel Biosciences, Inc. have?
Gentel Biosciences, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 1 registered, 6 abandoned, 1 cancelled.
What trademark classes does Gentel Biosciences, Inc. file in?
Gentel Biosciences, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Gentel Biosciences, Inc.'s most well-known trademarks?
Gentel Biosciences, Inc.'s registered trademark portfolio includes well-known marks such as SILVERQUANT. These are among 1 currently registered trademark in the portfolio.
What is Gentel Biosciences, Inc.'s trademark registration success rate?
Gentel Biosciences, Inc. has a 13% trademark registration rate, with 1 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.